TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response

The MiT/TFE family of transcription factors (MITF, TFE3, and TFEB), which control transcriptional programs for autophagy and lysosome biogenesis have emerged as regulators of energy metabolism in cancer. Thus, their activation increases lysosomal catabolic function to sustain cancer cell growth and...

Full description

Bibliographic Details
Main Authors: Sandra Pisonero-Vaquero, Chiara Soldati, Marcella Cesana, Andrea Ballabio, Diego Luis Medina
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/5/1186
_version_ 1827717153272365056
author Sandra Pisonero-Vaquero
Chiara Soldati
Marcella Cesana
Andrea Ballabio
Diego Luis Medina
author_facet Sandra Pisonero-Vaquero
Chiara Soldati
Marcella Cesana
Andrea Ballabio
Diego Luis Medina
author_sort Sandra Pisonero-Vaquero
collection DOAJ
description The MiT/TFE family of transcription factors (MITF, TFE3, and TFEB), which control transcriptional programs for autophagy and lysosome biogenesis have emerged as regulators of energy metabolism in cancer. Thus, their activation increases lysosomal catabolic function to sustain cancer cell growth and survival in stress conditions. Here, we found that TFEB depletion dramatically reduces basal expression levels of the cyclin-dependent kinase (CDK) inhibitor p21/WAF1 in various cell types. Conversely, TFEB overexpression increases p21 in a p53-dependent manner. Furthermore, induction of DNA damage using doxorubicin induces TFEB-mediated activation of p21, delays G2/M phase arrest, and promotes cell survival. Pharmacological inhibition of p21, instead, abrogates TFEB-mediated protection during the DNA damage response. Together, our findings uncover a novel and direct role of TFEB in the regulation of p21 expression in both steady-state conditions and during the induction of DNA-damage response (DDR). Our observations might open novel therapeutic strategies to promote cancer cell death by targeting the TFEB-p21 pathway in the presence of genotoxic agents.
first_indexed 2024-03-10T19:55:40Z
format Article
id doaj.art-9177d5d42b5d4ad3bfa972399ed09ecc
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T19:55:40Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-9177d5d42b5d4ad3bfa972399ed09ecc2023-11-19T23:58:41ZengMDPI AGCells2073-44092020-05-0195118610.3390/cells9051186TFEB Modulates p21/WAF1/CIP1 during the DNA Damage ResponseSandra Pisonero-Vaquero0Chiara Soldati1Marcella Cesana2Andrea Ballabio3Diego Luis Medina4Telethon Institute of Genetics and Medicine (TIGEM), High Content Screening facility, Via Campi Flegrei 34, 80078 Pozzuoli, ItalyTelethon Institute of Genetics and Medicine (TIGEM), High Content Screening facility, Via Campi Flegrei 34, 80078 Pozzuoli, ItalyTelethon Institute of Genetics and Medicine (TIGEM), High Content Screening facility, Via Campi Flegrei 34, 80078 Pozzuoli, ItalyTelethon Institute of Genetics and Medicine (TIGEM), High Content Screening facility, Via Campi Flegrei 34, 80078 Pozzuoli, ItalyTelethon Institute of Genetics and Medicine (TIGEM), High Content Screening facility, Via Campi Flegrei 34, 80078 Pozzuoli, ItalyThe MiT/TFE family of transcription factors (MITF, TFE3, and TFEB), which control transcriptional programs for autophagy and lysosome biogenesis have emerged as regulators of energy metabolism in cancer. Thus, their activation increases lysosomal catabolic function to sustain cancer cell growth and survival in stress conditions. Here, we found that TFEB depletion dramatically reduces basal expression levels of the cyclin-dependent kinase (CDK) inhibitor p21/WAF1 in various cell types. Conversely, TFEB overexpression increases p21 in a p53-dependent manner. Furthermore, induction of DNA damage using doxorubicin induces TFEB-mediated activation of p21, delays G2/M phase arrest, and promotes cell survival. Pharmacological inhibition of p21, instead, abrogates TFEB-mediated protection during the DNA damage response. Together, our findings uncover a novel and direct role of TFEB in the regulation of p21 expression in both steady-state conditions and during the induction of DNA-damage response (DDR). Our observations might open novel therapeutic strategies to promote cancer cell death by targeting the TFEB-p21 pathway in the presence of genotoxic agents.https://www.mdpi.com/2073-4409/9/5/1186TFEBp21DNA-damage responsecell cycleautophagycancer
spellingShingle Sandra Pisonero-Vaquero
Chiara Soldati
Marcella Cesana
Andrea Ballabio
Diego Luis Medina
TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
Cells
TFEB
p21
DNA-damage response
cell cycle
autophagy
cancer
title TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
title_full TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
title_fullStr TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
title_full_unstemmed TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
title_short TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
title_sort tfeb modulates p21 waf1 cip1 during the dna damage response
topic TFEB
p21
DNA-damage response
cell cycle
autophagy
cancer
url https://www.mdpi.com/2073-4409/9/5/1186
work_keys_str_mv AT sandrapisonerovaquero tfebmodulatesp21waf1cip1duringthednadamageresponse
AT chiarasoldati tfebmodulatesp21waf1cip1duringthednadamageresponse
AT marcellacesana tfebmodulatesp21waf1cip1duringthednadamageresponse
AT andreaballabio tfebmodulatesp21waf1cip1duringthednadamageresponse
AT diegoluismedina tfebmodulatesp21waf1cip1duringthednadamageresponse